Leo and DTU join forces in research  

A new cooperation in medical research could produce future blockbuster drugs

Leo Incubator, a business unit within the Leo concern, has made DKK 12 million available for research into reciprocal communication in bacteria at the Technical University of Denmark (DTU). If the research effort is successful, drugs could be developed that could ease the lives of patients with artificial heart valves, hip joints etc, reports Danish business daily newspaper Erhvervsbladet.

The work will be carried out by the newly founded QSI Pharma A/S, a DTU based company with 2 researchers from the university as the idea generators. Leo Incubator is providing administrative backup and management know-how while DTU, with a 15% stake in QSI, is renting premises to the company and employing the researchers. The idea is to enable the QSI researchers to concentrate fully on the development of potential blockbusters by relieving them of time-consuming business administration tasks.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×